StabiLux Biosciences
PrivateLast Round
Grant
Oct 19, 2020
Total Funding Raised
$1.25M
Company Overview
StabiLux Biosciences operates in Healthcare & Life Sciences and is based in Ann Arbor, Michigan. Its latest recorded funding round was a Grant round in October 2020.
StabiLux Biosciences is a biotechnology company that develops proprietary high-brightness fluorophores to improve reagents for flow cytometers used in biomedical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StabiLux Biosciences Comparables
Compare StabiLux Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biotium | 80% | |
| AAT Bioquest | 77% | |
| Bio-Rad Laboratories | 76% |
For institutional investors. Book with your work email.
StabiLux Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 19, 2020 | ||||
| Accelerator | Sep 24, 2020 | ||||
| Grant | Jun 25, 2020 | ||||
| Grant | Nov 7, 2017 | ||||
| Seed | Sep 29, 2017 | ||||
Grant | May 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
StabiLux Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cantilever Opportunity Fund, LP | SAFE |
| Ann Arbor SPARK | Grant, Accelerator |
| ID Ventures | Grant |
| Invest Michigan | Seed, Grant |
| National Science Foundation | Grant, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 19, 2020
$500K raised from Ann Arbor SPARK and NSF.
- Sep 24, 2020
$50K round from Ann Arbor SPARK and NSF.
For institutional investors. Book with your work email.
StabiLux Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StabiLux Biosciences's valuation, stock price, and market status.
Is StabiLux Biosciences a public or private company?
StabiLux Biosciences is a private company.
What is the current stock price of StabiLux Biosciences?
StabiLux Biosciences is a private company, so its shares have no public market price. Caplight tracks StabiLux Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StabiLux Biosciences worth (valuation)?
Valuation information for StabiLux Biosciences is not publicly available.
Can I buy StabiLux Biosciences stock?
StabiLux Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StabiLux Biosciences's last funding round?
StabiLux Biosciences's most recent funding round was Grant on October 19, 2020.
Who are the main investors in StabiLux Biosciences?
Key investors in StabiLux Biosciences include Cantilever Opportunity Fund, LP, Ann Arbor SPARK, ID Ventures, Invest Michigan, National Science Foundation.
Will StabiLux Biosciences IPO soon?
No public IPO plans have been announced for StabiLux Biosciences.
How can I track StabiLux Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in StabiLux Biosciences's shares on secondary markets.